Activity value 72china Supplier,Last transaction date:
2026-05-25
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for sanxia pharmaceutical (hubei yichang xiaoting) co. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 10 transactions, with a transaction quantity of 31058.9 and a transaction weight of 9000.
YearTransactionsQuantityWeight
202547165792.698108.3
20261031058.99000
Bill of lading data
<
1/15
>
Trade date
2026/05/25
B/L No.
108274642340
Suppliers
sanxia pharmaceutical (hubei yichang xiaoting) co.
Buyers
công ty cổ phần uv
Product description
NEOMYCIN SULPHATE, S/M, S/M MFG DATE: 2026.01.05, 2026.01.24 / TAMBORES DE 25 KG PARA USO INDUSTRIAL NEOMYCIN SULPHATE / BATCH: 202601204, 202601225 CREDITO 60 DIAS FECHA DE BL
Expand
Product description
NEOMYCINE SULFATE (PHARMACEUTICAL RAW MATERIAL) (THE CONSIGMENT CONTAINING NET WEIGHT IS 1620 KGS. WE HAVE DECLARED THE ITEM AS PER 1000 BOU, WHICH IS MENTIONED AS PER ATTACHED DOCUMENTS AND FINAL DRAP CLEARANCE CERTIFICATE)
Expand
sanxia pharmaceutical (hubei yichang xiaoting) co. is china Supplier,
and primarily engages in the import and export business of products such as neomycin sulphate,pharmaceutical raw material,r pharm.
According to the 52wmb.com global trade database, as of 2026-05-25, the company has completed 81 international trades,
with its main trading regions covering pakistan,brazil,vietnam etc.
The core products include HS29419090 etc,
often transported via shanghai etc,
and its main trading partners are baariq pharmaceuticals,poulvet pharmaceutical,my lab pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on sanxia pharmaceutical (hubei yichang xiaoting) co. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.